Jaffe , E.S., 2001.Tumours of haematopoietic and lymphoid tissues: Pathology and genetics,World health organization classification of tumours -
MacIntyreDA, 2010.Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups,Leukemia 24 788 -97
ZenzT., .Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): Dissecting the contribution of 17p deletion, TP53 mutation,, -
VossT., 2001.Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia,Int J Cancer 91 180 -6
TianQ., 2004.Integrated genomic and proteomic analyses of gene expression in mammalian cells,Mol Cell Proteomics 3 960 -9
UnwinRD, 2006.Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells,Blood 107 4687 -94
Xu , Y., 2014.Construction of protein profile classification model and screening of proteomic signature of acute leukemia,Int J Clin Exp Pathol 7 5569 -
UnwinRD, 2005.Quantitative proteomic analysis using isobaric protein tags enables rapid comparison of changes in transcript and protein levels in transformed cells,Mol Cell Proteomics 4 924 -35
WardE, 2014.,Cancer J Clin 64 83 -103
Dores G.M., 2012.Acute leukemia incidence and patient survival among children and adults in the United States,,Blood 119 34 -43
HerishanuY., 2013.Biology of chronic lymphocytic leukemia in different microenvironments: Clinical and therapeutic implications,Hematol Oncol Clin North Am 27 173 -206
2001.Pathology and genetics of tumours of haematopoietic and lymphoid tissues,Jaffe ES -
SeiterK, 2016.Therapy for relapsed acute lymphoblastic leukemia: Still a role for standard chemotherapy regimens?,Leuk Res 41 1 -2
AccordiB, 2010.Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL,PLoS One 5 e13552 -
Caligaris-CappioF,Hamblin TJ, 1999.B-cell chronic lymphocytic leukemia: A bird of a different feather,J Clin Oncol 17 399 -
DoresGM, 2007.Chronic lymphocytic leukaemia and small lymphocytic lymphoma: Overview of the descriptive epidemiology,Br J Haematol 139 809 -19
LiH, 2017.Chronic lymphocytic leukemia prognostic index: A new integrated scoring system to predict the time to first treatment in Chinese patients with chronic lymphocytic leukemia,Chin Med J 130 135 -
MulliganSP,TamCS, 2012.Chronic lymphocytic leukemia: Diagnosis and clinical staging, in advances in the treatment of B-cell chronic lymphoc,Leuk 6 -15
KanderovaV, 2016.High-resolution antibody array analysis of childhood acute leukemia cells,Mol Cell Proteomics 15 1246 -61
2015.Quantitative proteomic analysis reveals maturation as a mechanism underlying glucocorticoid resistance in B lineage ALL and rensensitization by JNK inhibition,Br J Haematol 171 595 -605
PriolaGM, 2015.Cerebrospinal fluid proteomics in children during induction for acute lymphoblastic leukemia: A pilot study,Pediatric Blood and Cancer 62 1190 -4
SligteNE, 2015.Kinase activity profiling reveals active signal transduction pathways in pediatric acute lymphoblastic leukemia: A new approach for target discovery,Proteomics 15 1245 -54
SahaS., 2014.2DGE and DIGE based proteomic study of malignant B-cells in B-cell acute lymphoblastic leukemia,EuPA Open Proteom 3 13 -26
ChoiDB, 2014.Aberrant proteomic expression of NSRP70 and its clinical implications and connection to the transcriptional level in adult acute leukemia,Leuk Res 38 1252 -9
Wang D., 2013.Differential protein analysis of lymphocytes between children with acute lymphoblastic leukemia and healthy children,Leuk Lymph 54 381 -6
BraoudakiM., 2013.Protein biomarkers distinguish between highand low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner,J Hematol Oncol 6 52 -
FossEJ, 2012.Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data sets,J Proteom Res 11 5005 -10
JiangN., 2011.Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL),J Proteom 74 843 -57
HollandM., 2011.ICAM1 expressions are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia,Blood 118 638 -49
2009.Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia,Proteom Sci 7 7 -
Gez S. CrossettB,ChristophersonRI, 2007.Differentially expressed cytosolic proteins in human leukemia and lymphoma cell lines correlate with lineages and functions,Proteins Proteom 1774 1173 -83
JohnstonHE, 2017.Integrated cellular and plasma proteomics of contrasting B-cell cancers reveals common, unique and systemic signatures,Mol Cell Proteom 16 386 -406
2016.Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia,Proteomics 16 1193 -203
HuangPY, 2016.Protein profiles distinguish stable and progressive chronic lymphocytic leukemia,Leukem Lymph 57 1033 -43
NesmiyanovPP,TolkachevBE,StryginAV, 2016.ZO-1 expression shows prognostic value in chronic B cell leukemia,Immunobiology 221 6 -11
EagleGL, 2015.Total proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia,Mol Cell Proteom 14 933 -945
AlsagabySA, 2014.Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia,J Proteom Res 13 5051 -62
2014.Quantitative proteomics to characterize specific histone H2A proteolysis in chronic lymphocytic leukemia and the myeloid THP-1 cell line,Int J Mol Sci 15 9407 -21
KashubaE, 2013.Proteomic analysis of B-cell receptor signaling in chronic lymphocytic leukaemia reveals a possible role for kininogen,J Proteom 91 478 -85
Redondo-Muñoz J. Matrix, ., -
O'Hayre M., 2010.Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis,PloS One 5 e11716 -
Rees-UnwinKS, 2010.Ribosome-associated nucleophosmin 1: Increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia,Br J Haematol 148 534 -43
FanAC, 2009.Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens,Nat Med 15 566 -71
SuX, 2009.Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemia,Proteom 9 1197 -1206
CateraR, 2008.Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation,Mol Med 14 665 -74
2008.Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicators,Leuk Lymph 49 751 -6
ChurchmanML, 2015.Efficacy of retinoids in IKZF1-mutated BCRABL1 acute lymphoblastic leukemia,Cancer Cell 28 343 -56
FossEJ, 2011.Genetic variation shapes protein networks mainly through non-transcriptional mechanisms,PLoS Biol 9 e1001144 -
SugimotoK., 2015.A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines,Cancer Science 106 1534 -43
IssaqHJ,VeenstraTD, 2008.Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE): Advances and perspectives,Biotechniques 44 697 -
AebersoldR,MannM, 2003.Mass spectrometry-based proteomics,Nature 422 198 -207